Androgen deprivation therapy and definitive radiotherapy for intact prostate cancer in the modern era: personalized medicine on the horizon
AME Clinical Trials Review · 2026-06 · 4 · 29-29
DOI: 10.21037/actr-25-133 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-06. Verfasst von Joshua R. Niska und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Niska, J. R., Yu, N. Y., Rwigema, J. M., James, S. E., Laughlin, B. S., Vargas, C. E., & Schild, S. E. (2026). Androgen deprivation therapy and definitive radiotherapy for intact prostate cancer in the modern era: personalized medicine on the horizon. AME Clinical Trials Review, 4, 29-29. https://doi.org/10.21037/actr-25-133
Vancouver
Niska JR, Yu NY, Rwigema JM, James SE, Laughlin BS, Vargas CE, et al. Androgen deprivation therapy and definitive radiotherapy for intact prostate cancer in the modern era: personalized medicine on the horizon. AME Clinical Trials Review. 2026;4:29-29. doi:10.21037/actr-25-133
BibTeX
@article{Niska2026,
author = {Niska, Joshua R. and Yu, Nathan Y. and Rwigema, Jean-Claude M. and James, Sarah E. and Laughlin, Brady S. and Vargas, Carlos E. and Schild, Steven E.},
title = {Androgen deprivation therapy and definitive radiotherapy for intact prostate cancer in the modern era: personalized medicine on the horizon},
journal = {AME Clinical Trials Review},
year = {2026},
volume = {4},
pages = {29--29},
doi = {10.21037/actr-25-133}
}
EUVIMED